Epstein-Barr_JJ
viral_JJ
latency_NN
is_VBZ
disrupted_VBN
by_IN
the_DT
immediate-early_JJ
BRLF1_NN
protein_NN
through_IN
a_DT
cell-specific_JJ
mechanism_NN
._.

Epstein-Barr_JJ
virus_NN
-LRB-_-LRB-
EBV_NN
-RRB-_-RRB-
,_,
the_DT
causative_JJ
agent_NN
of_IN
infectious_JJ
mononucleosis_NN
,_,
is_VBZ
a_DT
human_JJ
herpesvirus_NN
associated_VBN
with_IN
epithelial_JJ
cell_NN
malignancies_NNS
-LRB-_-LRB-
nasopharyngeal_JJ
carcinoma_NN
-RRB-_-RRB-
as_RB
well_RB
as_IN
B-cell_NN
malignancies_NNS
._.

Understanding_VBG
how_WRB
viral_JJ
latency_NN
is_VBZ
disrupted_VBN
is_VBZ
a_DT
central_JJ
issue_NN
in_IN
herpesvirus_NN
biology_NN
._.

Epithelial_JJ
cells_NNS
are_VBP
the_DT
major_JJ
site_NN
of_IN
lytic_JJ
EBV_NN
replication_NN
within_IN
the_DT
human_JJ
host_NN
,_,
and_CC
viral_JJ
reactivation_NN
occurs_VBZ
in_IN
EBV-associated_JJ
nasopharyngeal_JJ
carcinomas_NNS
._.

It_PRP
is_VBZ
known_VBN
that_IN
expression_NN
of_IN
a_DT
single_JJ
viral_JJ
immediate-early_JJ
protein_NN
,_,
BZLF1_NN
,_,
is_VBZ
sufficient_JJ
to_TO
initiate_VB
the_DT
switch_NN
from_IN
latent_JJ
to_TO
lytic_JJ
infection_NN
in_IN
B_NN
cells_NNS
._.

Cellular_JJ
regulation_NN
of_IN
BZLF1_NN
transcription_NN
is_VBZ
therefore_RB
thought_VBN
to_TO
play_VB
a_DT
key_JJ
role_NN
in_IN
regulating_VBG
the_DT
stringency_NN
of_IN
viral_JJ
latency_NN
._.

Here_RB
we_PRP
show_VBP
that_IN
,_,
unexpectedly_RB
,_,
expression_NN
of_IN
another_DT
viral_JJ
immediate-early_JJ
protein_NN
,_,
BRLF1_NN
,_,
can_MD
disrupt_VB
viral_JJ
latency_NN
in_IN
an_DT
epithelial_JJ
cell-specific_JJ
fashion_NN
._.

Therefore_RB
,_,
the_DT
mechanisms_NNS
leading_VBG
to_TO
disruption_NN
of_IN
EBV_NN
latency_NN
appear_VBP
to_TO
be_VB
cell-type_NN
specific_JJ
._.

